# Actinium Pharmaceuticals, Inc.: Form 8-K, filed May 29, 2026

- Company: [Actinium Pharmaceuticals, Inc.](/companies/atnm.md) (CIK 1388320)
- Form: 8-K
- Filed: 2026-05-29
- Accepted by EDGAR: May 29, 2026, 21:10 ET
- Period: 2026-05-27
- Accession: 0001213900-26-062935
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1388320/000121390026062935/ea0292691-8k_actinium.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1388320/000121390026062935/

## Items reported

- Item 3.01: Delisting notice
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1388320/000121390026062935/ea0292691-8k_actinium.htm

Filed May 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-062935. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.